Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CT › Waterbury › NPI 1760426969
Hospital

Saint Mary's Hospital, INC.

Saint Mary's Hospital, INC. was paid $163.27M by Medicaid between Jan 2018 and Dec 2024, across 591 billing codes. Its largest line is 99285, emergency room visit (most serious) — 22% of everything it billed.

33Billing provider infoSAINT MARY'S HOSPITAL, INC.
WATERBURY, CT 06706
33aNPI1760426969assigned 06/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$163.27M
24GClaims4,906,079
24DCodes billed591
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Connecticut

Rank by total paid#4 of 18
Median peer was paid$15.60M
This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018628,504$24.42M
2019696,766$24.96M
2020612,515$20.31M
2021705,903$22.17M
2022747,144$23.81M
2023782,138$24.01M
2024incomplete733,109$23.60M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 22% 74,610 64,459 $35.58M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 56,687 50,780 $18.17M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 80,794 72,660 $17.99M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.5% 72,902 62,119 $7.29M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.8% 42,550 36,972 $6.24M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.9% 9,607 9,093 $4.82M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 21,176 18,348 $2.79M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.6% 14,632 13,270 $2.65M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.4% 3,210 3,027 $2.33M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.4% 14,001 5,846 $2.32M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1.4% 2,765 2,458 $2.31M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 7,857 7,369 $2.19M
579 more codes
47562 1.3% 528 $2.15M
71046 Radiologic examination, chest; 2 views 1.3% 37,092 $2.08M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.3% 3,601 $2.04M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 16,386 $1.99M
70450 Computed tomography, head or brain; without contrast material 1.2% 19,809 $1.97M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.2% 2,973 $1.95M
96361 Intravenous infusion, hydration; each additional hour 1.1% 31,456 $1.88M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 29,087 $1.81M
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.1% 2,140 $1.80M
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1.1% 3,030 $1.77M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 20,572 $1.47M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 7,083 $1.45M
J9271 Injection, pembrolizumab, 1 mg <1% 214 $1.40M
J2350 Injection, ocrelizumab, 1 mg <1% 88 $1.37M
96375 Therapeutic injection; each additional sequential IV push <1% 31,766 $1.31M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 8,886 $1.30M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 10,121 $1.12M
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 14,977 $1000K
77067 Screening mammography, bilateral, including computer-aided detection <1% 8,764 $948K
93976 <1% 9,428 $882K
95811 <1% 1,071 $868K
97010 <1% 12,075 $810K
J0897 Injection, denosumab, 1 mg <1% 1,114 $790K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 7,488 $737K
71045 Radiologic examination, chest; single view <1% 16,309 $718K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 4,740 $674K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,580 $589K
84443 Thyroid stimulating hormone (TSH) <1% 56,938 $552K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 30,559 $551K
52356 <1% 168 $548K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,718 $477K
86900 <1% 12,831 $471K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 1,588 $446K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 4,208 $436K
70498 <1% 2,036 $385K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 11,108 $380K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,580 $376K
76770 <1% 3,475 $373K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 181,797 $353K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,512 $315K
76830 Ultrasound, transvaginal <1% 3,197 $314K
83036 Hemoglobin; glycosylated (A1C) <1% 53,211 $312K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 644 $298K
83718 <1% 40,916 $293K
76536 <1% 3,994 $291K
11043 <1% 823 $288K
94726 <1% 3,032 $287K
93971 <1% 3,999 $287K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 12,738 $267K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12,739 $266K
82947 <1% 130,911 $264K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 12,011 $260K
76641 <1% 2,814 $254K
82607 <1% 29,694 $251K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,194 $249K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 66,566 $242K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 6,728 $235K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 639 $222K
76801 <1% 2,108 $219K
93970 <1% 1,677 $217K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,399 $215K
0240U <1% 1,869 $213K
94060 <1% 1,120 $206K
82247 <1% 88,403 $203K
95816 <1% 1,616 $197K
76642 <1% 3,260 $191K
82040 <1% 89,561 $190K
72100 <1% 4,791 $189K
77066 Tomosynthesis, mammo <1% 1,560 $188K
73562 <1% 8,917 $187K
36415 Collection of venous blood by venipuncture <1% 196,685 $185K
93017 <1% 4,548 $174K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 34,502 $170K
71250 <1% 2,874 $165K
84439 <1% 28,524 $156K
S9480 Intensive outpatient psychiatric services, per diem <1% 1,203 $152K
96415 <1% 2,057 $151K
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education <1% 1,154 $147K
72110 <1% 2,189 $144K
49083 <1% 433 $142K
77065 Tomosynthesis, mammo <1% 1,309 $140K
73030 <1% 6,767 $138K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 12,209 $134K
73610 <1% 6,681 $134K
77080 <1% 1,358 $132K
96367 <1% 2,750 $119K
10061 <1% 427 $117K
73130 <1% 6,061 $114K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 706 $111K
82728 <1% 18,773 $108K
86480 <1% 2,536 $107K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 260 $107K
72141 <1% 839 $106K
36430 <1% 760 $102K
77063 Screening digital breast tomosynthesis, bilateral <1% 7,069 $100K
86803 <1% 11,657 $94K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 19,232 $94K
83550 <1% 20,940 $93K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 20,784 $93K
82310 <1% 129,859 $90K
73110 <1% 4,111 $87K
73630 <1% 5,713 $81K
84403 <1% 4,174 $77K
87086 Culture, bacterial; quantitative colony count, urine <1% 52,639 $76K
76882 <1% 1,534 $75K
73502 <1% 4,271 $74K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 355 $74K
50590 <1% 30 $74K
93225 <1% 1,299 $72K
83540 <1% 21,295 $71K
93458 <1% 58 $70K
72050 <1% 879 $70K
97161 <1% 1,794 $69K
49650 <1% 16 $68K
80061 Lipid panel <1% 20,347 $66K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,439 $65K
88142 <1% 5,456 $65K
80053 Comprehensive metabolic panel <1% 30,918 $62K
70486 <1% 2,479 $62K
83970 <1% 3,067 $61K
97597 <1% 849 $59K
96417 <1% 1,062 $56K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,132 $56K
97162 <1% 1,795 $55K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 17,707 $54K
73590 <1% 2,586 $53K
97014 <1% 758 $52K
82043 <1% 15,461 $52K
87522 Neg quan hep c or qual rna <1% 1,709 $51K
85027 <1% 27,742 $49K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 4,596 $49K
82746 <1% 7,046 $49K
82570 <1% 15,950 $48K
87070 <1% 20,139 $47K
10060 <1% 302 $47K
72040 <1% 2,159 $47K
86235 <1% 1,088 $44K
93798 <1% 529 $44K
93975 <1% 195 $41K
73560 <1% 1,668 $41K
19081 <1% 42 $40K
72125 Computed tomography, cervical spine; without contrast material <1% 6,187 $40K
73080 <1% 2,409 $40K
P9016 Red blood cells, leukocytes reduced, each unit <1% 403 $39K
80048 Basic metabolic panel (calcium, ionized) <1% 46,891 $38K
81329 <1% 665 $38K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 361 $37K
82374 <1% 129,972 $36K
70491 <1% 239 $34K
88342 <1% 1,128 $34K
88304 <1% 3,569 $33K
86706 <1% 4,605 $33K
72070 <1% 906 $32K
83735 <1% 34,529 $31K
86618 <1% 3,968 $30K
86038 <1% 4,355 $30K
93880 <1% 347 $30K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 48 $30K
73140 <1% 2,207 $30K
84153 <1% 3,279 $30K
80074 <1% 1,094 $29K
43251 <1% 33 $29K
86592 <1% 8,830 $29K
84202 <1% 2,247 $29K
87150 <1% 1,216 $29K
74019 <1% 3,141 $29K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 669 $29K
82465 <1% 41,014 $29K
74018 <1% 2,180 $28K
86003 <1% 492 $27K
82652 <1% 919 $27K
83655 <1% 2,575 $27K
81003 <1% 47,216 $27K
19301 <1% 12 $26K
97165 <1% 496 $26K
84702 <1% 11,489 $26K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,841 $26K
97166 <1% 552 $25K
84481 <1% 2,656 $25K
87340 <1% 5,948 $25K
73090 <1% 1,490 $25K
84146 <1% 2,015 $25K
87186 <1% 12,246 $24K
82105 <1% 2,185 $23K
83001 <1% 1,820 $23K
83525 <1% 2,644 $23K
84480 <1% 2,582 $23K
J2505 Injection, pegfilgrastim, 6 mg <1% 21 $22K
84402 <1% 1,192 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,515 $20K
84270 <1% 1,193 $20K
59025 Fetal non-stress test <1% 131 $19K
83002 <1% 1,464 $19K
85610 <1% 35,555 $19K
87338 <1% 1,769 $18K
77085 <1% 302 $18K
74183 <1% 72 $18K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 15 $18K
78306 <1% 87 $17K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 195 $17K
93923 <1% 311 $17K
87536 <1% 305 $17K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,701 $16K
82784 <1% 2,659 $16K
72131 <1% 303 $16K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 304 $15K
77062 <1% 1,048 $14K
86376 <1% 1,798 $14K
83520 <1% 1,299 $14K
82670 <1% 756 $14K
74220 <1% 127 $14K
86140 <1% 10,548 $14K
82951 <1% 1,261 $14K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 134 $13K
73221 <1% 67 $13K
85652 <1% 11,064 $13K
86762 <1% 3,335 $12K
97035 <1% 182 $12K
86200 <1% 1,790 $12K
83880 <1% 10,407 $12K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 401 $12K
87088 <1% 5,283 $12K
72170 <1% 1,696 $11K
87077 <1% 6,418 $11K
85730 <1% 9,214 $11K
86225 <1% 1,299 $11K
80076 <1% 18,418 $10K
87506 <1% 98 $10K
86160 <1% 752 $10K
70496 <1% 1,123 $9K
83516 <1% 1,457 $9K
86364 <1% 825 $9K
81001 <1% 15,873 $9K
86800 <1% 1,046 $9K
86696 <1% 625 $9K
82533 <1% 1,034 $9K
73551 <1% 577 $9K
83690 <1% 41,453 $9K
78014 <1% 28 $9K
86430 <1% 2,806 $8K
71101 <1% 778 $8K
83993 <1% 610 $8K
78264 <1% 25 $8K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 12 $8K
86920 <1% 751 $8K
86787 <1% 741 $8K
88112 <1% 373 $7K
87147 <1% 4,632 $7K
88307 <1% 665 $6K
86695 <1% 625 $6K
82627 <1% 387 $6K
G0379 Direct admission of patient for hospital observation care <1% 12 $6K
97116 <1% 135 $6K
82248 <1% 38,687 $6K
86765 <1% 589 $6K
90675 <1% 24 $6K
86769 <1% 163 $6K
73060 <1% 516 $6K
86255 <1% 685 $6K
87493 <1% 323 $6K
86334 <1% 1,028 $6K
84165 <1% 2,193 $6K
86735 <1% 535 $6K
86704 <1% 807 $5K
96411 <1% 87 $5K
90686 <1% 338 $5K
73564 <1% 90 $5K
12011 <1% 1,650 $5K
80164 <1% 1,087 $5K
82785 <1% 429 $5K
12001 <1% 2,285 $5K
82150 <1% 2,309 $5K
86141 <1% 825 $5K
41899 Unlisted procedure, dentoalveolar structures <1% 34 $4K
86360 <1% 144 $4K
84156 <1% 2,576 $4K
94010 <1% 1,723 $4K
84207 <1% 288 $4K
87075 <1% 3,988 $4K
G0378 Hospital observation service, per hour <1% 11,338 $4K
73700 <1% 60 $3K
87427 <1% 602 $3K
83020 <1% 1,556 $3K
77061 <1% 247 $3K
84450 <1% 91,533 $3K
88173 <1% 1,067 $3K
82550 <1% 7,932 $3K
87400 <1% 6,945 $3K
81376 <1% 15 $3K
29515 <1% 28 $3K
83630 <1% 233 $3K
87328 <1% 376 $3K
J0185 Injection, aprepitant, 1 mg <1% 46 $3K
83521 <1% 909 $3K
87045 <1% 602 $3K
73100 <1% 42 $3K
84478 <1% 41,044 $3K
87046 <1% 601 $3K
0011A <1% 358 $3K
82565 <1% 132,567 $3K
82140 <1% 1,260 $3K
87329 <1% 352 $3K
73660 <1% 359 $3K
85045 <1% 3,261 $2K
86258 <1% 161 $2K
85379 <1% 7,734 $2K
85018 <1% 3,085 $2K
86850 <1% 12,646 $2K
85014 <1% 2,886 $2K
87205 <1% 3,689 $2K
83010 <1% 876 $2K
12002 <1% 563 $2K
82523 <1% 210 $2K
86780 <1% 172 $2K
92950 <1% 13 $2K
76857 <1% 112 $2K
86381 <1% 118 $2K
81025 <1% 15,448 $2K
94618 <1% 285 $2K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 1,953 $2K
83090 <1% 205 $2K
86617 <1% 233 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 47 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,097 $2K
84550 <1% 3,657 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 161 $2K
36591 <1% 27 $1K
83721 <1% 259 $1K
80178 <1% 410 $1K
83883 <1% 485 $1K
96402 <1% 88 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 6,036 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 13 $1K
86355 <1% 144 $1K
86359 <1% 144 $1K
86357 <1% 144 $1K
82378 <1% 846 $1K
74241 <1% 14 $1K
87040 <1% 11,152 $1K
86705 <1% 156 $975.77
0004A <1% 27 $965.87
84100 <1% 14,888 $934.78
90715 <1% 4,599 $913.50
84460 <1% 91,281 $890.57
83498 <1% 44 $886.94
87653 <1% 28 $871.26
86901 <1% 12,832 $853.50
86709 <1% 119 $829.49
84484 <1% 39,155 $819.99
86015 <1% 101 $763.76
86694 <1% 65 $761.19
87081 <1% 146 $760.80
84132 <1% 131,319 $746.44
82977 <1% 946 $744.18
86708 <1% 97 $733.46
82653 <1% 76 $726.33
82435 <1% 129,974 $725.50
81596 <1% 31 $717.42
82805 <1% 2,021 $716.14
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,799 $691.15
84080 <1% 98 $677.76
83605 <1% 13,779 $650.32
84590 <1% 92 $648.82
86231 <1% 83 $646.97
J2359 Injection, olanzapine, 0.5 mg <1% 52 $644.54
84410 <1% 12 $609.48
0001A <1% 90 $602.23
96376 <1% 9,755 $596.07
82705 <1% 157 $587.25
83615 <1% 4,028 $575.93
82390 <1% 79 $570.43
76981 <1% 13 $568.08
51701 <1% 2,813 $555.39
76377 <1% 7,463 $551.43
84630 <1% 58 $489.15
86665 <1% 44 $484.96
80051 <1% 237 $443.06
0064A <1% 13 $440.00
87529 <1% 67 $435.63
86308 <1% 580 $429.23
16020 <1% 29 $428.03
86039 <1% 63 $426.40
82103 <1% 46 $411.53
82656 <1% 51 $394.70
86304 <1% 40 $384.63
87625 <1% 14 $371.76
73522 <1% 15 $358.59
J3490 Unclassified drugs <1% 74,835 $325.64
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 71 $319.99
82077 <1% 6,277 $314.72
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,303 $306.32
82088 <1% 12 $305.80
84520 <1% 132,005 $295.81
86664 <1% 42 $292.20
73552 <1% 14 $288.15
83695 <1% 27 $274.18
76870 <1% 1,241 $271.90
84255 <1% 14 $268.18
89051 <1% 783 $262.56
86812 <1% 15 $246.50
29125 <1% 52 $221.03
84075 <1% 88,441 $213.71
82495 <1% 14 $213.07
82330 <1% 838 $211.34
87807 <1% 1,474 $209.97
84425 <1% 12 $206.33
83921 <1% 17 $204.36
93041 <1% 4,609 $160.93
86677 <1% 32 $152.46
80185 <1% 37 $139.26
86431 <1% 39 $135.50
84466 <1% 14 $134.09
80177 <1% 52 $125.41
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,903 $101.70
86663 <1% 15 $100.24
84295 <1% 130,056 $98.91
83918 <1% 15 $94.32
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 939 $81.41
84155 <1% 88,159 $63.74
86300 <1% 141 $59.61
88300 <1% 13 $55.32
J1170 Injection, hydromorphone, up to 4 mg <1% 14,794 $55.30
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 38 $51.88
80047 <1% 151 $51.64
82553 <1% 1,412 $50.83
82948 <1% 4,438 $50.36
81243 <1% 770 $42.59
86403 <1% 5,015 $38.63
84703 <1% 12 $35.90
88312 <1% 9,059 $34.60
82232 <1% 29 $33.67
99152 <1% 1,641 $33.29
87076 <1% 14 $30.88
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 23,404 $29.39
83935 <1% 14 $28.36
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 35,575 $28.10
80143 <1% 758 $26.84
J2704 Injection, propofol, 10 mg <1% 37,905 $26.02
J0736 Injection, clindamycin phosphate, 300 mg <1% 22 $25.46
83930 <1% 15 $25.24
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 24,249 $23.50
51798 <1% 14 $22.56
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,435 $21.88
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 31,526 $19.73
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,634 $19.18
81002 <1% 4,874 $16.69
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,310 $13.65
80179 <1% 715 $13.42
71100 <1% 12 $12.49
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,771 $9.11
J1644 Injection, heparin sodium, per 1000 units <1% 9,365 $8.32
99153 Mod sedat endo service >5yrs <1% 1,372 $7.22
82962 <1% 2,587 $6.87
C9113 Injection, pantoprazole sodium, per vial <1% 3,006 $6.70
J0690 Injection, cefazolin sodium, 500 mg <1% 9,729 $6.62
J1953 Injection, levetiracetam, 10 mg <1% 310 $5.34
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,756 $4.65
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 5,177 $3.21
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 7,613 $2.72
70360 <1% 27 $2.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 16,460 $2.45
J7120 Ringers lactate infusion, up to 1000 cc <1% 473 $2.42
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,905 $2.42
J3010 Injection, fentanyl citrate, 0.1 mg <1% 18,338 $2.25
J3475 Injection, magnesium sulfate, per 500 mg <1% 6,889 $2.07
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 546 $1.71
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 496 $1.55
J3480 Injection, potassium chloride, per 2 meq <1% 1,868 $1.10
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 342 $1.05
J2550 Injection, promethazine hcl, up to 50 mg <1% 277 $1.00
J1630 Injection, haloperidol, up to 5 mg <1% 2,706 $1.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals <1% 326 $0.97
J1940 Injection, furosemide, up to 20 mg <1% 1,052 $0.80
G0475 Hiv antigen/antibody, combination assay, screening <1% 880 $0.77
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,585 $0.66
J8540 Dexamethasone, oral, 0.25 mg <1% 475 $0.27
J2060 Injection, lorazepam, 2 mg <1% 4,165 $0.26
J1836 Injection, metronidazole, 10 mg <1% 112 $0.25
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 13 $0.03
93226 0% 1,299 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 2,206 $0.00
51702 0% 145 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 2,800 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 328 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 390 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 476 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 2,649 $0.00
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml 0% 199 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 2,869 $0.00
94729 0% 2,998 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 439 $0.00
90714 0% 64 $0.00
J3486 Injection, ziprasidone mesylate, 10 mg 0% 50 $0.00
88313 0% 2,206 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 1,810 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 2,352 $0.00
82272 0% 143 $0.00
J0694 Injection, cefoxitin sodium, 1 gm 0% 815 $0.00
J7510 Prednisolone oral, per 5 mg 0% 97 $0.00
69209 0% 116 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 222 $0.00
A9531 Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries) 0% 14 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 170 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 561 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 2,201 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 199 $0.00
95957 0% 35 $0.00
76942 0% 45 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 371 $0.00
J1453 Injection, fosaprepitant, 1 mg 0% 90 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 0% 15 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 57 $0.00
76376 0% 108 $0.00
81206 0% 119 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 142 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 94 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 59 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 18 $0.00
84112 0% 12 $0.00
J3489 Injection, zoledronic acid, 1 mg 0% 15 $0.00
91300 0% 83 $0.00
81401 0% 24 $0.00
82800 0% 14 $0.00
77002 0% 12 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 19 $0.00
97803 0% 46 $0.00
84145 0% 12 $0.00
C1776 Joint device (implantable) 0% 16 $0.00
C1769 Guide wire 0% 2,748 $0.00
C1781 Mesh (implantable) 0% 659 $0.00
83009 0% 4,071 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 2,321 $0.00
Q3014 Telehealth originating site facility fee 0% 186 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 3,206 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 3,346 $0.00
96368 0% 294 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 3,052 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 414 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 572 $0.00
V2632 Posterior chamber intraocular lens 0% 543 $0.00
94760 0% 2,491 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 1,682 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 20 $0.00
11045 0% 2,539 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 301 $0.00
84157 0% 17 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 849 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 1,118 $0.00
88341 0% 346 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 32 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 510 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 130 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 127 $0.00
0352U 0% 68 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 531 $0.00
J0713 Injection, ceftazidime, per 500 mg 0% 42 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 289 $0.00
A4648 Tissue marker, implantable, any type, each 0% 41 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 202 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 0% 191 $0.00
85660 0% 14 $0.00
J9045 Injection, carboplatin, 50 mg 0% 43 $0.00
88311 0% 68 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 753 $0.00
J0456 Injection, azithromycin, 500 mg 0% 39 $0.00
J1815 Injection, insulin, per 5 units 0% 24 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 0% 63 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 40 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 61 $0.00
96377 0% 71 $0.00
91306 0% 13 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 12 $0.00
C1819 Surgical tissue localization and excision device (implantable) 0% 13 $0.00
94644 0% 16 $0.00
A9512 Technetium tc-99m pertechnetate, diagnostic, per millicurie 0% 14 $0.00
J9267 Injection, paclitaxel, 1 mg 0% 58 $0.00
91301 0% 188 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 15 $0.00
C1766 Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT)
Parent organizationTRINITY HEALTH OF NEW ENGLAND CORPORATION, INC.
Same official

Other billing entities under HARRIS, JAMES

Full network →
ProviderLocationPaid
Saint Francis Hospital and Medical CenterHartford, CT$266.39M
The Mercy Hospital INCSpringfield, MA$98.92M
Trinity Health of New England Provider Network Organization INCHartford, CT$41.97M
Riverbend Medical Group, INC.Springfield, MA$38.70M
System Coordinated Services, INCSpringfield, MA$18.54M
Brightside INCSpringfield, MA$11.41M
The Mercy Hospital INCHolyoke, MA$10.93M
Mercy Inpatient Medical Associates INC.Springfield, MA$6.96M
State of New York Comptrollers OfficeBuffalo, NY$6.05M
Saint Francis Care Medical Group, PCHartford, CT$2.00M
Saint Francis Hospital and Medical CenterHartford, CT$1.42M
Pioneer Valley Cardiology Associates, INCSpringfield, MA$1.31M
Mercy Medical Group, INC.Springfield, MA$1.08M
Saint Francis Hospital and Medical CenterHartford, CT$382K
Prater Volunteer Rescue Squad INCGrundy, VA$331K
Diabetes and Lifestyle Management, LLCDerry, NH$273K
Mercy Specialist Physicians INCSpringfield, MA$101K
Health Access, INC.Clarksburg, WV$85K
Gibson County Podiatry LLCMilan, TN$83K
Saint Francis Hospital and Medical CenterHartford, CT$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.